(March 26 19:01) Reuters.com Business
Drugmaker Mylan NV's merger with Pfizer Inc's off-patent branded drug unit, Upjohn, would now close in the second half of 2020 due to the delays surrounding coronavirus, the companies said on Thursday.
You can find the original article
here